Study details
Enrolling now
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714
University of Alabama at Birmingham
NCT IDNCT03759522ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
120
Study length
about 7.2 years
Ages
18–65
Locations
1 site in AL
About this study
This trial is testing a treatment to measure neuroinflammation using a PET scan. The goal is to see if people with chronic pain and fatigue have higher levels of neuroinflammation than healthy individuals, as measured by the PET scan.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take DPA-714 PET/MRI
PhasePhase 1
Primary goalNeuroinflammation will be measured in healthy volunteers and compared to neuroinflammation in individuals with pain and fatigue, as measured with [F-18]DPA-714-PET/MRI
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low9%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Neuroinflammation will be measured in healthy volunteers and compared to neuroinflammation in individuals with pain and fatigue, as measured with [F-18]DPA-714-PET/MRI.
Body systems
Neurology, Musculoskeletal